Rockefeller University

Digital Commons @ RU
Student Theses and Dissertations

2013

Novel Molecules from Environmental DNADerived Type II Polyketide Biosynthetic Gene
Clusters
Ryan W. King

Follow this and additional works at: http://digitalcommons.rockefeller.edu/
student_theses_and_dissertations
Part of the Life Sciences Commons
Recommended Citation
King, Ryan W., "Novel Molecules from Environmental DNA-Derived Type II Polyketide Biosynthetic Gene Clusters" (2013). Student
Theses and Dissertations. Paper 176.

This Thesis is brought to you for free and open access by Digital Commons @ RU. It has been accepted for inclusion in Student Theses and
Dissertations by an authorized administrator of Digital Commons @ RU. For more information, please contact mcsweej@mail.rockefeller.edu.

NOVEL MOLECULES FROM ENVIRONMENTAL
DNA-DERIVED TYPE II POLYKETIDE
BIOSYNTHETIC GENE CLUSTERS

A Thesis Presented to the Faculty of
The Rockefeller University
in Partial Fulfillment of the Requirements for
the degree of Doctor of Philosophy

by
Ryan W. King
June 2013

© Copyright by Ryan W. King 2013

NOVEL MOLECULES FROM ENVIRONMENTAL DNA-DERIVED
TYPE II POLYKETIDE BIOSYNTHETIC GENE CLUSTERS
Ryan W. King, Ph.D.
The Rockefeller University 2013
Natural products have been a significant source of new drugs over the
past 25 years. In fact, the origins of nearly 70% of antibacterial, antifungal,
antiparasitic and antiviral small molecule drugs are in natural products
(Newman and Cragg 2007). A significant proportion of natural product drugs
and leads have been isolated from microbes (Newman and Cragg 2007).
However, the discovery of novel natural products from microbes faces the
growing hurdle of rediscovering known metabolites. Streptomyces is a
microbe that has been a particularly rich source of natural products;
however, it has been predicted that the last easily accessible novel
Streptomyces metabolite will be found within the next few years (Watve,
Tickoo et al. 2001). Finding a new source rich in natural products would be
very beneficial to the development of new drugs.
One potential new source of natural products is the plethora of
uncultured bacteria found in environmental soil samples. It is estimated that
greater than 99% of bacteria from soil samples are recalcitrant to culturing in
a

laboratory

setting.

A

culture-independent

approach

of

extracting

environmental DNA (eDNA) from soil and cloning it into a library was
leveraged to take advantage of the genetic diversity of uncultured microbes.
Uncultured microbes have been found to be rich in type II polyketide
synthase (PKS) gene clusters (Kieser, Bibb et al. 2000). PKS gene clusters produce a
structurally diverse collection of aromatic natural products. The nascent polyketide in
these pathways is produced by a conserved minimal PKS, composed of an αketosynthase, β-ketosynthase and acyl carrier protein. In order to access the structural
diversity encoded by type II PKS gene clusters from uncultured bacteria, environmental
DNA (eDNA) libraries were constructed from desert soil. These libraries were found to
be rich in PKS genes and cosmids containing minimal PKS genes were recovered from
the eDNA library using β-ketosynthase sequences as probes. The recovered clones
containing minimal PKS genes from the eDNA library were screened for the ability to
confer the production of clone-specific molecules to cultured Streptomyces albus.
One of the recombinant Streptomyces clones was found to produce erdacin, a 26carbon polyketide with both a novel carbon backbone and a novel pentacyclic ring
arrangement. The novel structure and pentacyclic ring arrangement of erdacin
raised questions as to the biosynthetic origins of this metabolite encoded by
the eDNA-derived V167 clone. A biosynthetic analysis of wild type and
transposon mutant V167 cultures indicated that erdacin arises from the
heterodimerization of two 13-carbon monomer subunits that are both derived
from octaketide precursors. These two 13-carbon subunits arise from two
different second cyclizations, but both have the same three carbons excised
from their 16-carbon octaketide precursors.

In addition to erdacin, a number of other clone specific novel and
known metabolites were characterized from cultures of S. albus conjugated
with the wild-type V167 clone. These metabolites included utahmycin A,
utahmycin B and 8-O-methylutahmycin A. The structure of Utahmycin A is
novel and utahmycin B has not been previously observed in a biological
system. The identification of the novel structure, erdacin, provides tangible evidence
that eDNA-derived type II PKS gene clusters may encode the biosynthesis of molecules
that are distinct from known metabolites identified by traditional culture-based strategies.
The isolation of additional distinct novel metabolites from the same eDNA
clone suggests these gene clusters are a rich source of novel natural products.
In future studies, the heterologous expression of eDNA-derived type II PKS gene
clusters is likely to be a rewarding avenue to access the structural diversity of
natural products encoded by uncultured soil bacteria.
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CHAPTER 1

Introduction and Background
Natural Products
Natural products have been a significant source of new drugs over the
past three decades. In fact, the origins of nearly 70% of antibacterial,
antifungal, antiparasitic and antiviral small molecule drugs are in natural
products (Newman and Cragg 2007). In addition to antimicrobial properties,
natural products have a wide range of therapeutic applications from
anticancer to cholesterol-lowering agents. Natural products have been
isolated from a wide range of sources including microbial, marine, plant and
even animal sources. A significant proportion of natural product drugs and
leads have been isolated from microbes (Newman and Cragg 2007). It has
been estimated that almost two thirds of clinically useful antibiotics are
derived from the primarily soil dwelling Streptomyces (Kieser 2000).
The majority of known bacterial natural products are not necessary for
growth of the bacteria producing them. As a result, these natural products
are referred to as secondary metabolites. Bacteria will expend the energy to
produce secondary metabolites to gain a competitive advantage in their
environment and utilize these metabolites for a number of applications,
1

including defense, cell-cell signaling and siderophore iron scavenging. The
frequently complex structures of bacterial secondary metabolites are
produced by groups of biosynthetic enzymes. The genes encoding for these
biosynthetic enzymes are typically grouped in clusters in the genome of the
microbe. This gene clustering is believed to have helped facilitate the
evolution of natural product biosynthetic gene clusters (Maplestone, Stone et
al. 1992).
Traditionally to isolate natural products from bacteria, the bacterium
must first be cultured from a sample. Bacterial cultures are then extracted
with organic solvents and the metabolites produced can be fractionated and
assayed for desired activities. However, the number of new natural products
discovered by this culture-dependant approach is declining (Fox 2006). While
there are many reasons for this downward trend, one major hurdle has been
the rediscovery of already known metabolites. In fact, while Streptomyces has
been a particularly rich source of natural products, it has been predicted that
the last easily accessible novel Streptomyces metabolite will be found within
the next few years (Watve, Tickoo et al. 2001). Finding a new source rich in
natural products would be beneficial to the development of new drugs.

2

Uncultured Microbes and Metagenomics
One potential new source of natural products is the large number of
uncultured microbes found in the environment. It has been predicted that
less than 1% of the bacteria in a given soil sample can be easily cultured
(Torsvik, Salte et al. 1990; Torsvik, Goksoyr et al. 1990; Hugenholtz, Goebel
et al. 1998; Torsvik, Daae et al. 1998; Torsvik and Ovreas 2002; Rappe and
Giovannoni 2003). The large portion of uncultured bacteria in a given soil
sample are likely to encode for the production of a diverse collection of
natural products. Difficulties in growing these microbes from soil samples
hamper traditional culture-dependant approaches from accessing these
metabolites. In fact, traditional culture dependant approaches have most
likely missed the majority of natural products in nature (Hugenholtz, Goebel
et al. 1998; Rappe and Giovannoni 2003). Uncultured bacteria represent a
large potential untapped source of novel natural products.
Fortunately, culture-independent metagenomic methods have been
developed to study the genetic diversity of all the microbes in an
environmental sample. Metagenomic methods avoid the limitations of
traditional

culture-dependant

methods

by

directly

extracting

DNA

representing the entire microbial genetic diversity from the environment.
Environmental DNA (eDNA) extracted from nature contains an incredible
amount of genetic material, including secondary metabolite biosynthetic gene
clusters. This eDNA must then be cloned into a culturable host to enable
3

future analysis. To accomplish this eDNA can be ligated into a cosmid vector,
packaged into lambda phage and transfected into E. coli (Brady 2007). This
cosmid cloning method captures 30-50 kb pieces of eDNA in a single cosmid.
Since the genes responsible for the biosynthesis of natural products are
typically clustered together, it is possible to capture an entire biosynthetic
gene cluster on a single cosmid (Handelsman, Rondon et al. 1998). Large
libraries of eDNA clones, some containing natural product biosynthetic gene
clusters, enable the exploration of eDNA-derived genes through subsequent
screening or sequencing studies.

Functional metagenomic screening
One approach to access the structural diversity encoded in eDNA
libraries is through a functional metagenomic screen (Figure 1). Functional
metagenomic screening relies on the expression of eDNA clones in a
heterologous host to identify natural products. In functional metagenomic
screening, individual clones with phenotypes indicative of small molecule
production are identified in eDNA libraries by high throughput assays. These
phenotypes that indicate small molecule production include pigmentation,
altered colony morphology and/or antibiosis. The pigmentation of clones has
been used to identify a number of metabolites from soil eDNA including the
pigments indigo (1), violacein (2) and the turbomycins (3) (Figure 2)
(MacNeil, Tiong et al. 2001; Brady, Chao et al. 2001; Gillespie, Brady et al.
2002; Lim, Chung et al. 2005). Furthermore, eDNA libraries hosted in E. coli
4

can be screened for antibiosis in top agar overlay assays to detect zones of
inhibition against test bacteria such as B subtilis. Clone specific metabolites
from eDNA clone hits in these overlay assays have been characterized
leading to the discovery of a novel isonitrile functionalized indole (4) and a
collection of long-chain N-acylated amines (5) (Figure 2) (Brady and Clardy
2000; Brady and Clardy 2005).

(DNA) Homology Screening

Functional Screening

eDNA Library

eDNA Library

Use general or focused gene targets as
probes to recover individual eDNA clones
Host A

Host B

Host C
Individual biosynthetic cluster of interest

Heterologous

Expression
Heterologous Host

Pigmentation Colony Morphology Antibiosis

Small Molecules

Heterologous Expression
or Enzymatic Biosynthesis

Figure 1: Functional and Homology-based metagenomic screening strategies.
Functional screening relies on heterologous expression while the entire eDNA library is
assayed in simple high throughput assay. Homology-based screening identifies individual
clones of interest by PCR that can be subsequently recovered and heterologously expressed.
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Figure 2: Compounds identified by functional metagenomic screening.

While the terragine (6) compounds have been isolated from the
heterologous expression of soil eDNA in S. lividans, E. coli has been the host
utilized in many functional metagenomic studies (Wang, Graziani et al. 2000;
Banik and Brady 2010). However, it is predicted that E. coli is unable to
successfully heterologously express much of the genetic information encoded
by eDNA (Gabor, Alkema et al. 2004). In order to access more of the genetic
diversity of eDNA, libraries have been constructed in broad-host-range
vectors that could be moved into multiple phylogenetically distinct bacteria
for functional screening (Courtois, Cappellano et al. 2003; Martinez, Kolvek
et al. 2004; Aakvik, Degnes et al. 2009; Craig, Chang et al. 2009). One study
utilized a broad-host-range vector to construct and screen eDNA libraries in
six diverse hosts: Agrobacterium tumefaciens, Burkholderia graminis,
Caulobacter vibrioides, Escherichia coli, Pseudomonas putida and Ralstonia
metallidurans. This study demonstrated that eDNA clones will present
6

distinctive phenotypes in different hosts and that the same phenotype is
rarely conferred to two different hosts (Craig, Chang et al. 2009; Craig,
Chang et al. 2010).
In addition to small molecules, functional metagenomic screening has
been used to find proteins of interest, including phage lysins. In fact, a
functional metagenomic screen has been developed and used to express 29
phage lysins from environmental samples of animal feces and earthworm
guts (Schmitz, Daniel et al. 2008; Schmitz, Schuch et al. 2010).

Functional

metagenomic screening is a powerful technique to gain access to the genetic
diversity encoded by uncultured bacteria.

Homology-based metagenomic screening
Homology-based metagenomic screens take advantage of the sequence
homology between previously sequenced biosynthetic genes and the
unidentified biosynthetic genes of uncultured bacteria. In homology-based
screening, degenerate polymerase chain reaction (PCR) primers are designed
from previously sequenced conserved regions of a biosynthetic gene of
interest. PCR screening with these degenerate primers enables the
identification and recovery of individual clones, which contain a homologous
gene, from an eDNA library (Figure 1). These degenerate primers can be used
to find new derivatives of known metabolites by targeting relatively rare or
pathway-specific biosynthetic genes. Alternatively, these primers can be
designed to identify novel structures by targeting conserved general
7

biosynthetic genes found in a class of compounds. Once a clone with a gene of
interested is recovered from an eDNA library, it can be moved into an
appropriate heterolgous host for expression.
New derivatives of known metabolites
A number of studies have utilized homology-based metagenomic
approaches to identify genes that can be used to develop new derivatives of
known compounds (Donia, Hathaway et al. 2006; Schmidt and Donia 2009;
Ziemert, Ishida et al. 2010). Banik et al. have used a PCR screen targeting
OxyC, a glycopeptide oxidative coupling enzyme, to identify and recover a
number of glycopeptide biosynthetic gene clusters from a soil eDNA library
(Banik and Brady 2008; Banik, Craig et al. 2010). One of these recovered
gene clusters was found to contain three sulfotransferases that were
subsequently used to produce novel mono-, di- and trisulfated glycopeptide
congeners from the teicoplanin aglycone (Figure 3) (Banik and Brady 2008).
A follow up study found additional tailoring enzymes that were used to
generate a collection of 15 new sulfated, glycosylated, halogenated and
methylated glycopeptide congeners (Banik, Craig et al. 2010).
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Figure 3: Sulfated glycopeptides.
Three eDNA-derived sulfotransferases were used to produce mono-, di- and trisulfated
glycopeptide congeners from teicoplanin aglycone.

Novel Structures
Homology-based metagenomic screens can be designed to find novel
structures by targeting conserved general biosynthetic genes found in a class
of compounds. Type-II polyketide synthase (PKS) gene clusters contain a
highly conserved minimal PKS composed of two ketosynthase genes (KSα
and KSβ) and an acyl carrier protein (discussed in more detail below). Type II
PKS genes first became targets of homology-based metagenomic screens
when two KSβ genes were cloned from eDNA in 1997 (Seow, Meurer et al.
1997). High throughput sequencing studies have indicated that eDNA
contains an abundance of novel PKS gene clusters (Wawrik, Kerkhof et al.
2005; Pang, Tan et al. 2008; Warwrik, Kutliev et al. 2007)). However, it has
been a challenge to identify eDNA clones with intact gene clusters that can
successfully heterologously express small molecules (Piel, Hui et al. 2004;
9

Schirmer, Gadkari et al. 2005; Courtois, Cappellano et al.2003). In fact, prior
to the work presented in this thesis, no new metabolites had been isolated
from eDNA-derived type II PKS gene clusters (Figure 4).

Figure 4: Homology-based metagenomics screen for Type II PKS gene clusters
Scheme for the recovery and heterologous expression of Type II PKS clones from an eDNA
library.

10

After the discovery of erdacin, a novel polyketide with both a novel
carbon skeleton and ring system, a number of other aromatic polyketides
have been isolated from soil libraries (Figure 5) (King, Bauer et al. 2009).
These metabolites include compound 8, a second eDNA-derived type II
polyketide found to have both a novel carbon skeleton and ring system (Feng,
Kallifidas et al. 2011). The antibiotic fasamycins (9) were isolated from soil
and found to inhibit FabF of type II fatty acid biosynthesis (Feng, Kallifidas
et al. 2011; Feng, Chakraborty et al. 2012). A collection of fluostatins (10) and
the methicillin-resistant Staphylococcus aureus (MRSA)-active antibiotic
tetarimycin A (11) have also been isolated from soil libraries (Feng, Kim et al.
2010; Kallifidas, Kang et al. 2012). In addition to isolating polyketides, a
homology-based metagenomic screen targeting oxy-tryptophan dimerization
has found an eDNA-derived gene cluster that encodes the biosynthesis of the
antitumor substance BE-54017 (12) (Chang and Brady 2011). Homologybased metagenomic screening is proving to be a rewarding avenue to access
the structural diversity encoded by uncultured bacteria.
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Figure 5: Metabolites isolated in homology-based metagenomic screening.
Four aromatic polyketides and the antitumor substance BE-54017 were all isolated from soil
eDNA libraries.

Polyketides
Polyketides are an incredibly valuable class of natural products
produced by plants, bacteria and fungi. The over 10,000 compounds in this
class have therapeutic applications as antibiotic, immunosuppressant,
anticancer, antifugal, antiparasitic and cholesterol-lowering drugs (Figure
6a) (Walla, Bearden et al. 2002; McMurry and Begley 2005; Lombó,
Abdelfattah et al. 2009). Polyketides are subdivided into three classes based
on their enzymatic architecture: type I, type II and type III (Staunton and
Weissman 2001; Fujii 2008). Type I polyketide synthetases are made up of
large multifunctional proteins that each contain multiple functional domains.
These catalytic domains, including a ketosynthase (KS), acyltransferase, acyl
carrier protein (ACP) and other modification domains, are organized into
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modules. Type I PKSs are further divided into multi-modular (mPKS) and
single modular iterative (iPKS) categories. Type II PKSs are composed of a
number of separate individual enzymes that form a multi-enzyme complex.
Type III PKSs have a simple architecture compared to other polyketides.
They are composed of a homodimer of condensation subunits and can utilize
acyl-CoA without the use of an ACP.
Most bacterial aromatic polyketides are encoded by type II PKS gene
clusters (Fujii 2008). Type II polyketide gene clusters contain a conserved
genetic arrangement known as the minimal PKS, which is composed of an αketosynthase (KSα), a β-ketosynthase (KSβ; aka. chain length factor) and an
ACP. The minimal PKS is responsible for synthesizing the nascent polyketide
by iteratively condensing malonyl-CoA units (Figure 6b). The minimal PKS is
also responsible for catalyzing the first cyclization of the nascent polyketide it
produces. Nature has derived an astonishing array of post-PKS and tailoring
enzymes that cyclize, aromatize, reduce, rearrange and functionalize nascent
polyketides into an incredibly diverse collection of natural products (Figure
6a) (McDaniel, Khosla et al. 1995; Matharu, Cox et al. 1998 Shen 2000;
Hertweck, Luzhetskyy et al. 2007).
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Figure 6: Type II Polyketides and the minimal PKS.
A) Examples of type II polyketides include the antibiotics actinorhodin (13) and tetracycline
(14), the antitumor oviedomycin (15), the antifungal jadomycin B (16) and the anticancer
drug doxorubicin (17). B) The highly conserved minimal PKS (KSα, KSβ and ACP) of type II
PKS gene clusters iteratively condenses malonyl-CoA units into a nascent polyketide.

The iterative use of the minimal PKS typically makes type II PKS gene
clusters smaller than other pathways encoding comparably complex
molecules. This makes type II PKS pathways an attractive target for
homology-based metagenomic screening, because entire type II PKS gene
clusters are more easily captured on a single 30 to 50 kb eDNA cosmid insert.
Furthermore, these biosynthetic systems only require universal substrates,
which will be present in a heterologous host, to produce the nascent
polyketide. The use of universal precursors by the biosynthetic machinery
will help enable expression in a heterologous host. In fact, there is extensive
precedent for the expression of type II PKS gene clusters in Streptomyces.
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Furthermore, even a truncated gene cluster with an intact minimal PKS can
be functional. As a result, it maybe possible to determine the novelty of a
metabolite encoded by an incomplete truncated type II PKS gene cluster
captured on a cosmid.
Type II PKS genes are an ideal target for homology-based
metagenomic screening of eDNA libraries to find novel natural products
because type II PKS pathways produce structurally diverse metabolites, are
small enough to capture on a single cosmid, require universal substrates and
have precedent of being heterologously expressed in Streptomyces. The
exploration of type II PKS gene clusters from eDNA libraries is likely a
rewarding avenue to gain access to an incredible amount of the structural
diversity encoded by uncultured bacteria.
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CHAPTER 2

Materials and Methods
General Experimental Procedures
Streptomyces albus J1074 was used for heterologous expression
studies.

1H

and 2D NMR data were obtained on a Bruker Avance-600

spectrometer.

13C

NMR spectra were obtained on a Bruker Avance-400,

Bruker Avance-800 spectrometer or Bruker Avance-900 spectrometer.
Melting points were obtained on a Stanford Research Systems MPA100
OptiMelt melting point apparatus. A Varian Cary 100-Bio UV-vis
spectrophotometer was used to collect UV data. And a Bruker Tensor-27
spectrometer was used to obtain IR data.

eDNA Library Construction and Formatting
Soil collected in Utah (UT) or the Anza-Borrego (AB) desert in
California was used to construct a cosmid eDNA library following methods
previously described (Brady 2007; Banik and Brady 2008). Soil was incubated
for two hours at 70°C in lysis buffer (2% SDS (w/v), 100 mM Tris-HCl, 100
mM EDTA, 1.5 M NaCl and 1% CTAB (w/v)). Large particulates were
removed from the sample by centrifugation at 4,000 × g for 30 min. DNA was
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then precipitated by the addition of 0.6 volumes of isopropyl alcohol and
pelleted by centrifugation at 4,000 × g for 30 min. The resulting pellet was
washed with 70% ethanol and resuspended in TE. This DNA was gel purified
on a 1% agarose gel for 16h at 20V. The resulting high molecular weight
eDNA was blunt-ended (End-It, Epicentre), ligated into pWEB or pWEB-TN
(Epicentre) and packaged into lambda phage. E. coli EC100 was transfected
and 4,000 - 16,000 colonies per plate were plated on a LB plates with the
appropriate antibiotic selection. Matching glycerol stock (15% glycerol) and
DNA miniprep pairs were made from the cells scraped from each library
plate. The miniprep DNA from each of these 4,000-16,000 member library
pools were arrayed in 8 X 8 grids. To make screening of the library easier,
DNA from the rows and columns of this 8 X 8 grid were pooled. These pooled
rows and columns were further combined to yield master aliquots, each
representing a single 8X8 grid of minipreps.

PCR Screening of eDNA Libraries for KSβ Genes
The constructed eDNA libraries were for screened for KSβ genes by
PCR. Full-length KSβ genes were amplified from eDNA library pools using
the following pair of degenerate PCR primers (Seow 1997): dp:KSα, 5’ TTC
GGS GGX TTC CAG WSX GCS ATG and dp:ACP, 5’ TCS AKS AGS GCS
AXS GAS TCG TAX CC (X=deoxyinosine). The 25 µl PCR reactions each
contained 50 ng of eDNA template, 2.5 µM of each primer, 2 mM dNTPs, 1X
ThermoPol Reaction Buffer (New England Biolabs), 0.5 U Taq DNA
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polymerase (New England Biolabs) and 5% DMSO. A touchdown PCR
protocol was used in the initial screening of the libraries: denaturation (95°C;
45s), annealing (touchdown of 65°C to 58°C over 8 cycles D-1°C, followed by
58°C for 35 cycles; 1min) and extension (72°C; 2 min). Amplicons of the
correct predicted size (~1.5 kb) were identified by gel electrophoresis, gel
purified and sequenced by Sanger sequencing (Biotic Solutions).

Clone Recovery from eDNA libraries
As described above, sub-library pools with PKS containing clones were
initially identified by PCR screening of eDNA for KSβ sequences. Individual
clones of interest were then recovered from the corresponding glycerol stock
in the eDNA library using successive rounds of library dilution and PCR
screening. Briefly, a 10-4 dilution of the corresponding library glycerol stock
resuspended with LB to an OD600=0.2. was prepared. This 10-4 dilution (20 µl)
was then added to each of the individual wells of two to four 96-well
microtiter plates prefilled with LB (with the appropriate antibiotic selection).
These plates were incubated at 30°C overnight and 1 µl of this cell culture
from each well was used as template in whole cell PCR. Individual colonies
from PCR positive wells were then screened by colony PCR to identify
individual clones containing KSβ sequences. In some cases a second round of
dilution PCR screening of a single PCR positive well was required before
individual colony PCR could be utilized.
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eDNA Clone Sequencing
PKS containing cosmids recovered from the eDNA libraries were
initially sequenced by 454 pyrosequencing (Roche) by Memorial Sloan
Kettering Cancer Center Genomics Core Laboratory. Reads were processed
with Newbler (Roche) and Velvet (Zerbino and Birney 2008). Sequence gaps
between assembled contigs generated during 454 sequencing were filled by
primer walking (Biotic Solutions). The size and deduced role of the open
reading frames of sequenced cosmids were predicted using Glimmer
(Salzberg, Delcher et al. 1998), SoftBerry (Tyson et al. 2004) and BLAST
(Gish and States 1993). MacVector was used for sequence manipulation.

Clone Retrofitting and Integration into S. albus
Clones recovered from the eDNA libraries were retrofitted so that they
could be integrated into Streptomyces for heterologous expression studies.
The cassette used for retrofitting was constructed from the integrating vector
pOJ436. pOJ436 was digested with DraI and ligated with SmaI cut pBC. The
resulting vector was digested with XbaI and SpeI to create the desired
retrofitting cassette. Recovered eDNA clones were digested with rare
restriction enzymes (AvrII, NheI or PstI) to ensure that only the pWEB or
pWEB-TNC vector was cut and not the eDNA insert. The XbaI/SpeI cut
pOJ436 cassette was ligated directly into eDNA clones cut with AvrII or
NheI. The V167 clone was one such clone digested with AvrII for ligation into
the retrofitting cassette. Clones cut with PstI were blunt ended (End-It,
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Epicentre) and ligated into a blunt ended retrofitting cassette. The retrofitted
clones were then transformed into E. coli S17-1 and conjugated into S. albus
using standard Streptomyces conjugation protocols (Kieser, Bibb et al 2000).

Expression, Isolation and Characterization of Erdacin and
Juglomycin F from the V167 Clone
A spore stock of S. albus transformed with the retrofitted V167 clone
(25 mL) was inoculated into 75 mL of modified supplemented minimal
medium (SMM). Cultures larger than 75 mL yielded lower titers of erdacin.
Modified SMM contained: 819 mL PEG 6000 (6.1%), 25 mL MgSO4⋅7H2O (24
g/L), 100 mL TES Buffer (0.25 M, pH 7.2), 2 mL Glucose (50% w/v), 1 mL
SMM Trace Element Solution, 1 mL casamino acids (20% w/v) and 25 mL
Glycine (20%). Uniformly labeled 13C-erdacin was isolated from V167 cultures
grown in modified SMM containing uniformly labeled
uniformly labeled

13C-glycine.

13C-glucose

and

Erdacin labeled with [1,2-13C]acetate was

obtained by feeding V167 cultures grown in modified SMM three equal
portions of a sodium acetate solution at 24, 48 and 72 hours to attain a final
acetate concentration of 1.1 mM [1,2-13C]acetate and 2.2 mM naturally
abundant acetate.
V167 cultures were incubated for 4 days at 30°C and 250 rpm. The pH
of these cultures was adjusted to 3 with HCl and they were extracted two
times with an equal volume of ethyl acetate. The dried extracts were
dissolved in methanol (2-4 mL/L of culture) and passed through a SPE
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Previal C-18 plug. The sample was then dried, redissolved in 1-2 mL of
methanol, and partitioned by reversed phase HPLC (XBridge C18, 10 × 150
mm, 5 mm, gradient (Table 1) of acetonitrileand water with 0.1% formic acid,
7 mL/min). Fractions containing erdacin (14.9 min) and juglomycin F (8.6
min) were dried down overnight in a speed vac and analyzed by MS and
NMR. Plate-like crystals of erdacin were obtained by slow evaporation from a
mixture of acetonitrile and water. X-ray crystallography was done by E.
Lobkovsky

at

Cornell

University

and

deposited

in

Crystallographic Data Centre (CDCC).

Table 1: HPLC gradient for isolating erdacin and juglomycin F
% Water with 0.1%
Time (min)

formic acid

% Acetonitrile

Initial

80

20

2

80

20

26

50

50

27

0

100

32

0

100

35

80

20

21

the

Cambridge

CUPRAC Antioxidant assay of Erdacin
The antioxidant activity of erdacin was determined using the CUPRAC
antioxidant assay (Apak, Kubilay, et al 2004). Cupric chloride dihydrate (10
mM in water, 25 µL), 25 µL 1M ammonium acetate and 25 µL 7.5 mM
neocuproine (in ethanol) were added to the wells of a 96-well plate. Control
wells of the reaction solution containing 25 µL of water, 25 µL ammonium
acetate (1 M) and 25 µL of ethanol were prepared. Two fold serial dilutions
(final concentration from 400 mM to 95 fM) of erdacin and ascorbic acid were
prepared. Each of the serial dilutions was added (25 µL) to a well containing
the 75 µL reaction or control mixtures.
After incubating at room temperature for one hour, the absorbance of
each well at 450 nm was measured on a 96-well plate reader. Recorded
absorbances of the ascorbic acid dilution series were blanked against a
reagent blank. The erdacin dilution series was blanked against a reagent
blank and further adjusted by subtracting the absorbance of a well
containing 25 µL of the appropriate erdacin dilution, 25 µL of water, 25 µL of
1M ammonium acetate and 25 µL of ethanol. Absorbance vs. concentration
was plotted and the molar absorptivity (ε) under the reaction conditions was
calculated from the slope of the linear range for both erdacin (2.58 × 104 L
mol-1cm-1) and ascorbic acid (1.29 × 104 L mol-1cm-1). The observed value for
ascorbic acid was comparable to the previously reported value of 1.59 × 104 L
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mol-1cm-1. The molar absorptivity (ε) calculation where A is absorbance, L is
pathlength, ε is molar absorptivity, c is concentration and m is the slope of
the line plotted in the experiment:
A=L×ε×c
m=L×ε
εerd = (m erd)/(L) = (5157.1 L mol-1)/(0.2cm) = 2.58 × 104 L mol-1cm-1
εascorbic acid = (mascorbic acid)/(L) = (2574.5 L mol-1)/(0.2cm) = 1.29 × 104 L mol-1cm-1

Expression, Isolation and Characterization of Utahmycin
A, Utahmycin B and 8-O-methylutahmycin A
A number of metabolites were observed under alternative culture
conditions of the V167 clone. These metabolites were isolated and
characterized. A spore stock of S. albus transformed with the retrofitted V167
clone (75 mL) was inoculated into two 1 L flasks of modified R2YE medium.
Modified R2YE medium was prepared by adding 10 mL KH2PO4 (0.5%), 80
mL CaCl22H2O (3.68%), 15 mL L-proline (20%), 25 mL TES buffer (5.73%,
pH 7.2), 2 mL R2 trace element solution, 5 mL NaOH (1M) and 50 mL yeast
extract (10%) to a sterile 800 mL solution containing 103 g of sucrose, 250 mg
K2SO4, 10.12 g MgCl26H2O, 10 g glucose and 100 mg casaminoacids.
After incubating at 30°C with shaking (250 or 300 rpm) for 7-14 days,
the pH of these cultures was adjusted to 3 with HCl and extracted with an
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equal volume of ethyl acetate twice. The dried, crude extracts were then
fractionated by silica flash chromatography using a chloroform/methanol
gradient in which 100-150 mL fractions were collected for each of the
following chloroform/methanol ratios: 100:0, 99:1, 97:3, 95:5, 90:10, 80:20 and
0:100. The 99:1 fraction was found to contain both utahmycin A and B by
TLC. This fraction was further partitioned by reversed phase HPLC
(XBridge C18, 10 × 150 mm, 5 mm, gradient (Table 2) of acetonitrile and
water with 0.1% formic acid, 7 mL/min). The fractions containing utahmycin
A (16.5 min, 1 mg/L) and B (12.0 min, 2.5 mg/L) were dried down and
analyzed by HRMS and NMR. The structure of utahmycin A was confirmed
by X-ray crystallography	
   of	
   crystals	
   obtained	
   by	
   slow	
   evaporation	
   from	
  
dichloromethane. An alternative HPLC gradient (Table 3) was used to isolate
8-O-methylutahmycin A, observed in some R2YE cultures of V167. 8-Omethylutahmycin A (25.0 min, less than 0.5mg/L) was characterized by
1HNMR

and HRMS.

Table 2: HPLC method for isolating utahmycin A and B
% Water with 0.1%
Time (min)

formic acid

% Acetonitrile

Initial

80

20

2

80

20

32

0

100

37

0

100

40

80

20

24

Table 3: HPLC method for isolating 8-O-methylutahmycin A
% Water with 0.1%
Time (min)

formic acid

% Acetonitrile

Initial

80

20

2

80

20

22

50

50

27

0

100

30

80

20

Expression and Isolation of Prechrysophanol
Prechrysophanol was observed in cultures of the wild type V167 grown
in R2YE media for 14 days and in cultures of Erd20 transposon mutants
grown in SMM. Pure prechrysophanol was obtained by Dr. John Bauer from
ethyl acetate extracts of wild type V167 grown in R2YE for 14 days at 30°C
and 250 rpm. A linear HPLC gradient (Table 4) of acetonitrile and water with
0.1% formic acid was used to isolate prechrysophanol (14.5 min). Dr. John
Bauer elucidated the structure of prechrysophanol by NMR and X-ray
crystallography. NMR and MS was used to confirm the presence of
prechrysophanol in cultures of Erd20 transposon mutants in this thesis.
Table 4: HPLC method for isolating prechrysophanol
% Water with 0.1%
Time (min)

formic acid

% Acetonitrile

Initial

80

20

2

80

20

26

40

60

27

0

100

32

0

100

35

80

20

25

Transposon Mutagenesis of V167 and Anaylsis of the
Transposon Mutants
Transposon mutagenesis of the retrofitted V167 cosmid was carried out
using the Genome Priming System with GPS -2.1 (NEB). Two independent 19
®

µL GPS reaction mixtures (1X GPS Buffer, 0.01 µg pGPS2.1 Donor DNA, 300
ng V167 cosmid, and 1U TnsABC* Transposase) were incubated for 10 min at
37°C. After adding 1 µL of Start Solution, the reactions were incubated at
37°C for an additional hour, heat inactivated for 10 min at 75°C and
transformed into EC100 E. coli (Epicentre). Transformants that grew on
chloramphenicol

(12.5

µg/mL)

plates

were

pooled,

minipreped

and

transformed into electrocompetent S17-1 E. coli.
Using sequencing Primer S (ATA ATC CTT AAA AAC TCC ATT TCC
ACC CCT; NEB) 150 unique transposon mutants were sequenced to
determine the location of the individual transposon insertions. Unique
transposon mutants were individually mated into S. albus and visually
screened for phenotypic changes on mannitol soya plates. Spore stocks of
individual transposon mutants, which either exhibited a phenotypic change
or were found in genes of interest, were inoculated into 75 mL cultures of
modified SMM. After shaking (250 rpm) at 30°C for 4 days, these cultures
were extracted twice with an equal volume of ethyl acetate. The pH of the
remaining aqueous layer was adjusted to 3 with HCl and extracted two more
times with an equal volume of ethyl acetate. The ethyl acetate extracts were
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dried, dissolved in methanol (200 µL) and analyzed by analytical LC-MS
(XBridge C18 (4.6 × 150 mm; 5 mm), 1.5 mL/min, acetonitrile and water
with 0.1% formic acid gradient).
Table 5: Analytical HPLC method used for transposon mutant analysis
% Water with 0.1%
Time (min)

formic acid

% Acetonitrile

Initial

80

20

2

80

20

22

0

100

27

0

100

30

80

20

Table

6:

HPLC

method

used

to

purify

SEK34,

dehydromutactin
% Water with
Time (min)

0.1% formic acid

% Acetonitrile

Initial

80

20

20

65

35

25

50

50

26

0

100

30

0

100

33

80

20

35

80

20

Table 7: HPLC method used to purify SEK4b and AUR367
% Water with
Time (min)

0.1% formic acid

% Acetonitrile

Initial

85

15

25

80

20

26

0

100

30

0

100

33

85

15

35

85

15

27

SEK34b,

mutactin

and

Expression, Isolation and Characterization of SEK4b,
AUR367, mutactin, dehydromutactin, SEK34 and SEK34b
from V167 Mutants
The compounds present in extracts from S. albus transformed with
transposon mutants in Erd4, 5 and 22 were purified and characterized by MS
and NMR. Transposon mutants were grown and extracted in the same
manner described for wild type V167 cultures. SEK34 (5.9 min) and SEK34b
(9.8 min) were isolated from crude extracts of the ΔErd22 mutant with an the
HPLC gradient (Table 6) of acetonitrile and water with 0.1% formic acid.
Mutactin (6.9 min) and dehydromutactin (10.4 min) were purified from
extracts of the ΔErd4 GPS mutant using the same HPLC conditions. SEK4b
(8.1 min) and AUR367 (12.2 min) were isolated from cultures of the ΔErd5
mutant using an alternative HPLC gradient (Table 7) of acetonitrile and
water with 0.1% formic acid. MS and 1H NMR data were used to confirm the
identity of each known compound. SEK4b (HR-ESI-MS m/z 285.0791, calcd.
for C16H13O5, 285.0763; SEK34b) was crystallized from acetonitrile:water and
its structure was confirmed by X-ray crystallography.
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CHAPTER 3

Results
Library Construction and Screening for Type II PKS
Pathways
In order to access the genetic diversity of uncultured microbes, the lab
constructed a ten million-member cosmid eDNA mega-library from soil
collected from the desert in Utah (UT). Degenerate primers targeting
conserved regions of the KSα and ACP of the minimal PKS were used by Dr.
John Bauer to amplify full-length KSβ sequences from the UT eDNA library.
Sequencing of these KSβ amplicons revealed that, of the 21 KSβ genes
amplified from the UT eDNA library, only one showed greater than 80%
identity to a previously sequenced KSβ gene (Figure 7). A rule of thumb
based on BLAST searches of KSβ genes indicates that two KSβ genes with
greater than 80% identity likely encode for the same metabolite. While two
KSβ genes with less than 80% identity likely encode for different metabolites.
The low identity these UT eDNA-derived KSβ genes had with previously
sequenced KSβ genes suggests they are not associated with known PKS gene
clusters and likely encode for novel metabolites.
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UT VB4
UT E6
UT WC8
UT N5
UT XA1
UT XA3
UT WC3
UT N8
Actinorhodin
D a u n or u bic in - dox or u bic in
UT XA4
UT L6
UT WA4
UT WC6
UT K5
UT L5
UT XC8
V167 - Erdacin
UT M5
Jadomycin C
UT VB2
UT Q8
0.05

Figure 7: Phylogenic tree of sequenced KSβ amplicons from the UT library.
KSβ amplicons from the UT library sequenced by Dr. John Bauer. Only the UT-N8 KSβ
amplicon showed greater than 80% identity to a previously sequenced actinorhodin KSβ
gene. The low identity the other KSβ amplicons had with known genes indicates they are not
associated with known PKS gene clusters and likely encode for novel metabolites.

Later, a second multimillion-member cosmid eDNA library was
constructed by the lab from soil obtained from the Anza-Borrego (AB) desert
in California. Screening of the AB library pools with degenerate primers
indicated that the AB library is rich in type II PKS genes. Roughly one in
every 12,000 clones in the AB library contains a KSβ gene. This high
frequency of KSβ genes in the library may represent many unique gene
clusters or a few profuse gene clusters. To distinguish these possibilities, KSβ
gene amplicons, generated during the PCR screening of the AB library pools,
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were sequenced to determine if the AB library was rich in unique KSβ genes.
Of the 61 KSβ genes sequenced, 31 likely represent unique PKS gene clusters
(Figure 8). Of these 31 unique KSβ genes identified in the AB library, 30 have
less than 80% identity to previously sequenced KSβ genes and likely encode
for novel metabolites. One KSβ gene makes up 38% (23/61) of the KSβ genes
detected in the AB library. The closest homolog to this abundant KSβ gene is
from the actinorhodin pathway of S. coelicolor. A second unique KSβ gene
with homology to the actinorhodin gene cluster of S. coelicolor is represented
8 times. Two unique KSβ genes with closest homologs from S. antibioticus
were both represented 3 times and the remaining 27 unique KSβ genes were
each represented once. This sequencing data suggests the AB library is a rich
source of unique novel type II PKS gene clusters.
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1142
1107
Fredericamycin
1199
361
1177
1111
Lactonamycin
365
Enterocin
66
152
Medermycin
Naphthocyclinone
Granaticin
Erdacin
1117
Actinorhodin
102
166
354
161
D a u n or u bic in - dox or u bic in
1190
1123
1170
1134
1179
192
345
1105
1215
1118
363
848
1136
383
1210
103
894
8
Oviedomycin
1172
Jadomycin C
0.05

Figure 8: Phylogenic tree of sequenced KSβ genes amplified from the AB library.
Of the 31 unique KSβ genes identified in the AB library, 30 had less than 80% identity to a
previously sequenced KSβ gene and likely encode for novel metabolites.
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Recovery and Heterologous expression of eDNA-derived
Type II PKS pathways
PKS containing clones were recovered from the eDNA library and were
heterologously expressed in order to access the structural diversity encoded
by these gene clusters from uncultured bacteria. Clones containing PKS gene
clusters were recovered from the libraries using KSβ genes as probes in
successive rounds of library dilution and PCR screening. Dr. John Bauer
recovered twelve unique eDNA clones containing type II PKS gene clusters
from the UT eDNA library for heterologous expression studies. And with
Paula Calle’s assistance, nearly two dozen more clones containing PKS genes
were recovered from the other AB library during the course of this work.
Knowing that any PKS gene clusters from the library that could be
heterologously expressed in E. coli would likely have been identified in
earlier phenotypic screens of the library, an alternative heterologous host,
Streptomyces, was selected for expression studies. The predominantly soil
dwelling

gram-positive

Streptomyces

is

synonymous

with

secondary

metabolite production and produces two-thirds of clinically useful antibiotics
derived from natural sources (Kieser, Bibb et al. 2000). Streptomyces have
extensive precedent as a successful heterologous host. Furthermore, nearly
all of the identified KSβ genes in this work have closest homology with KSβ
genes from Streptomyces. In fact, only one of 31 KSβ genes identified in the
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AB library had a closest homolog from outside Streptomyces. The closest
homolog of this gene was with an Actinomadura verrucosospora KSβ gene.
Recovered clones from the libraries containing type II PKS gene clusters were
retrofitted so that they could be conjugated into Streptomyces for
heterologous expression studies. Rare restriction enzymes (AvrII, NheI, PstI
or PsiI) were used to remove PKS gene containing eDNA inserts from the
library construction vector, without cutting the eDNA insert. The resulting
intact linear eDNA was then ligated into the integrating Streptomyces shuttle
vector pOJ436. These retrofitted clones were transformed into E. coli S17-1
donor strain and conjugated into Streptomyces using standard Streptomyces
conjugation protocols. Dr. John Bauer successfully retrofitted and conjugated
eight clones from the UT library into S. albus. Retrofitting and conjugation of
the AB library clones was done by Dr. Sean Brady and myself, respectively,
with the assistance of Paula Calle.
While other Streptomyces species were explored, Streptomyces albus
proved to be an exceptional, laboratory friendly heterologous host because of
its fast growth rate, ample sporulation and ease of mating. These factors
helped facilitate both the conjugation of eDNA-derived Type-II PKS gene
clusters into S. albus and the characterization of the molecules these
pathways encode for. Eight of the clones recovered from the UT library were
retrofitted with the genetic elements necessary for integration into
Streptomyces and were successfully transformed into S. albus.
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Recombinant S. albus clones from the UT and AB libraries were then
screened for the production of clone specific metabolites. Antibacterial
overlays, color production, TLC and HPLC-MS analysis were used to
identified clone specific metabolites from cultures and crude extracts of
recombinant clones (Figure 9). Five of the recombinant strains from the UT
library were first observed by Dr. John Bauer to produce clone specific
metabolites. An equivilant number of recombinant strains from the AB
library were also observed to produce clone specific metabolites by visual
inspection, TLC, or HPLC-MS of crude extracts. Two of these clones from the
UT library (V167 and X26) and two clones from the AB library (848 and 1105)
were examined in this work. However, the V167 clone was selected for a proof
of principle study because, it produced large quantities (15-20 mg L-1) of a
purple clone specific metabolite (King, Bauer et al. 2009; Bauer, King et al.
2010).
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Figure 9: S. albus transformed with eDNA-derived PKS clones were screened for
the production of clone specific metabolites.
Representative images of the screening process. A) Recombinant S. albus on MS agar plates
to screen for colored metabolite production. The V167 and X26 clone are pictured. B) Crude
neutral and acid ethyl acetate extracts of cultures spotted on a lawn of B. anthrasis in an
antibacterial disk diffusion assay for four clones. C) Analytical LCMS trace of crude V167
culture extracts. V167 was selected for further studies because of the large quantities of
clone specific metabolite it produced.
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Isolation

and

Structural

Characterization

of

eDNA

Encoded Natural Products
To learn more about the molecules encoded by eDNA-derived Type-II
PKS gene clusters, the major clone specific metabolite of the recombinant S.
albus V167 clone was isolated and structurally characterized. Attempts were
made to isolate and structurally characterize metabolites from other clones,
including the X26 clone recovered from the UT library. However, the array of
clone specific metabolites from the X26 clone appeared to be unstable and
attempts to isolate them were unsuccessful. Efforts were focused on the
isolation and structural elucidation of one clone specific metabolite produced
in large quantities by the V167 clone.
Cultures of S. albus transformed with the retrofitted V167 clone were
grown in modified supplemented minimal medium (SMM). After incubating
at 30°C for 4 days, the cultures were acidified to pH 3 and extracted with
ethyl acetate. This crude extract was passed through a SPE Previal C-18
plug and further partitioned by reversed phase HPLC to isolate the major
metabolite, erdacin (HRMS (ESI) m/z 475.1037 [M+H]+, calcd. for C26H19O9,
475.1029). An extensive 1- and 2-D NMR analysis of naturally abundant and
uniformly

13C-labeled

erdacin utilizing 1HNMR,

13CNMR,

COSY, HMBC,

HMQC and INADEQUATE was used to assemble a potential structure of the
metabolite (Figure 10a).
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Proton NMR revealed six aromatic protons, two methyls and one
deshielded methanetriyl (4.29 ppm). The six aromatic protons included a
triplet, three doublets and two protons in a multiplet. HMBC and COSY
showed the triplet (7.28 ppm) and two of the doublets (6.92 and 7.16 ppm)
formed a spin system. The remaining aromatic doublet (6.73 ppm) must
couple with at least one of the protons in the multiplet (7.40 ppm). Given the
complexity of the multiplet, a second d-t-d spin system can be assumed. This
second spin system was confirmed in 1HNMR and HMBC of chemically Omethylated erdacin where this multiplet was resolved into a distinct triplet
and doublet (data not shown).
Carbon NMR was done on uniformly

13C-labeled

erdacin to increase

carbon signal intensity. This carbon NMR data confirmed 26 carbon signals
including the two methyl carbons, four carbonyls, two deshielded sp3
hybridized carbons and 18 olefins. HMBC and HMQC further showed the two
methyl groups were methyl ketones, where one was attached to an olefin (C4) and the other to C-13 (64.6 ppm). Based on

13C

chemical shift, the two

remaining carbonyls include an unsaturated ketone (C-1, 188.8 ppm) and a
carboxylic acid (C-24, 176.6 ppm). Deshielding on three of the olefins
suggested they were attached directly to heteroatoms. And HMQC revealed
six olefins that were directly attached to the six aromatic protons.
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The H-7, 8 to 9 spin system can be connected into an aromatic ring
fragment with the olefins C-6, 10 and 11 based on HMBC correlations
between these hydrogens and carbons. C-10 is one of the olefins attached
directly to a heteroatom. HMQC determined the 4.29 ppm proton singlet was
attached to a deshielded sp3 hybridized carbon (C-13, 64.6 ppm). HMBC
correlations from this H-13 singlet to C-5, 12, 14, 24, 25 and 26 enabled the
assembly of a fragment containing the two deshielded sp3 hybridized carbons,
two olefins, the carboxylic acid and one of the methyl ketones. This fragment
could then be connected to the H-7, 8 to 9 spin fragment to form partial
structure 18-1 through two correlations between H-13 to C-11 and H-7 to C-5
(Figure 10a).
Based on HMBC correlations, the H-17, 18 to 19 spin system could also
be assembled into an aromatic ring fragment with olefins C-16, 20 and 21.
Deshielding of C-21 in carbon NMR suggests it is directly attached to a
heteroatom. The placement of the unsaturated ketone (C-1) adjacent to C-21
to form fragment 18-2 is consistent with observed chemical shifts and 2D
INADEQUATE NMR data.
These two partial structures (18-1 and 18-2) could be connected based
on two key HMBC 1H-13C correlations to the olefin C-15 from H-17 and H-13.
However, five carbons (C-2, C-3, C-4, C-22 and C-23) could not be assigned
with certainty because of weak NMR signals. These remaining carbons
included three olefins and required two ring closures to meet unsaturation
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requirements. One of these olefins was attached to a methyl ketone and
another was directly attached to a heteroatom (Figure 10b). There were a
limited number of ways to attach these remaining pieces to partial structure
18-3 while closing two additional rings. Presented structure 18 is the
possibility most consistent with all of the collected NMR data. However, it is
difficult to distinguish by NMR this structure from the alternative structure
where the positions of the C-2 hydroxyl and the C-4 methyl ketone are
switched (Figure 10b).
Ultimately,

the

structure

of

erdacin

was

resolved

by

X-ray

crystallography of crystals obtained by slow evaporation from acetonitrile and
water (Figure 10c). The structure of erdacin revealed a potential C-2 hydroxyassisted C-22 carbonyl tautomerization that could explain the weak and
broad NMR signals observed in this region of the molecule. This
tautomerization could also explain the disappearance of the C-23 methyl
signal in deuterated, protic NMR solvents (Figure 11).
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Figure 11: Hydroxy-assisted tautomerization of erdacin.
Time course charting the rapid loss of the 2.53 ppm C-23 methyl signal from 1HNMR of
erdacin in MeOD-d4. This is likely the result of a C-2 hydroxy-assisted C-22 carbonyl
tautomerization.

42

The X-ray structure confirmed that erdacin is a novel metabolite.
Neither the erdacin carbon skeleton nor the erdacin pentacyclic (6-6-5-6-6)
ring system are substructures in known natural products (Figure 12). While
pentacyclic ring systems with the same number of 5- and 6-membered rings
are known, the particular arrangement of the erdacin ring system is novel.
The pentacyclic backbone of erdacin is functionalized with acetyl groups,
hydroxyls, a ketone and a carboxylate. The structural elucidation of erdacin
provides evidence that eDNA-derived type II PKS gene clusters can encode
for metabolites that are structurally distinct from those identified by
traditional culture-dependent studies.
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Figure 12: The novel structure of erdacin.
Both the carbon skeleton and the pentacyclic ring arrangement of erdacin are novel.
Juglocombin is a previously reported metabolite with the same number and order of 5- and 6membered rings, but the ring system is arranged differently.

Sequencing of PKS Containing eDNA-derived Clones
In order to develop a better understanding of the type-II PKS gene
clusters recovered from the eDNA library, the V167 clone was sequenced
(Figure 13a). Several contigs resulted from Dr. John Bauer’s 454 sequencing
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of the V167 clone. Primer walking, conducted for this thesis, to fill the gaps
between these contigs proved not to be a trivial task due to the very high GC
content of the eDNA insert. The completed sequencing efforts revealed the 20
kb erdacin gene cluster containing 22 predicted ORFs. These 22 ORFs
include the minimal PKS, a ketoreductase, a cyclase, and an aromatase
expected from a PKS gene cluster. Sequencing of the erdacin minimal PKS
genes revealed they are most closely related to the minimal PKS genes of the
naphthocyclinon, actinorhodin, granaticin and medermycin pathways (Figure
13b). Additionally, a collection of post-PKS enzymes, regulatory proteins, a
transporter, and several hypothetical proteins are also encoded for by the
erdacin gene cluster.
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18: MarR family transcription factor
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Figure 13: The erdacin gene cluster.
A) The erdacin gene cluster. B) Erdacin minimal PKS genes are most closely related to the
minimal PKS genes of medermycin, actinorhodin, granaticin and naphthocyclinon gene
clusters.
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In addition to sequencing the V167 clone, a number of additional
clones from the UT and AB libraries were sequenced by Dr. John Bauer and
myself, respectively. Sequencing of the X26 clone from the UT library
revealed a truncated PKS gene cluster with a minimal PKS (Figure 14). A
cosmid that captured an incomplete PKS gene cluster from eDNA could
explain the array of unstable clone specific metabolites observed in cultures
of S. albus harboring the X26 clone.

Gene cluster color key
Minimal PKS
Sugar/PKS Biosynthetic
Regulatory
Hypothetical/other

Heterologous Expression
in Streptomyces
Unstable Metabolites

Figure 14: Sequencing of the X26 clone.
The X26 clone contains a minimal PKS and a truncated PKS gene cluster. Heterologous
expression of the truncated X26 clone lead to the production of a number of uncharacterized
unstable metabolites.

Erdacin Activity
With the structure of erdacin elucidated, several assays were
conducted to explore the potential activity of erdacin. Erdacin (50-100µg/disk)
was assayed against a number of Gram-positive and Gram-negative microbes
in an antibacterial agar disk diffusion assay. However, no zone of inhibition
was observed against the tested microbes. Assays of erdacin against
mammalian cell lines also showed no activity. Erdacin did, however, show
strong antioxidant activity. In fact, erdacin demonstrated twice the
antioxidant activity as the known antioxidant ascorbic acid (vitamin C) as
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determined by a standard antioxidant copper reduction assay (Apak, Kubilay,
et al 2004). Since the bacteria that encodes for erdacin remains uncultured, it
is difficult to know the function of erdacin in its native microbe.

Isolation of Juglomycin F
A number of clone specific novel and known metabolites, in addition to
erdacin, were characterized from cultures of S. albus conjugated with the
eDNA-derived V167 clone to develop a better understanding of this type-II
PKS. In addition to the major metabolite erdacin, a second clone specific
metabolite was identified in four-day-old SMM cultures of the V167 clone. S.
albus cultures were extracted and this metabolite was isolated by reversed
phase HPLC. NMR and MS analysis established the structure of this
molecule was the known compound juglomycin F, confirming earlier
observations by Dr. John Bauer of V167 in alternative culture conditions. The
structure of juglomycin F maps onto half of the erdacin structure, providing a
hint to the biosynthetic origin of erdacin. This observation raised the
possibility that erdacin is derived from the heterodimerization of juglomycin
F and a second 13-carbon subunit (Figure 15).
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Figure 15: Retrobiosynthetic scheme for the production of erdacin.
Erdacin appears to arise from two 13-carbon monomers. Juglomycin F, isolated from V167
cultures, maps onto half of the erdacin structure. The hypothetical second 13-carbon
polyketide contains the carbons needed to complete the structure of erdacin.

Isolation

and

Characterization

of

Utahmycins

and

Prechrysophanol
A number of additional compounds were observed in alternative
culture conditions of S. albus conjugated with the V167 clone.

In these

alternative conditions, V167 cultures were incubated for a longer time (7-14
days) in R2YE media instead of SMM media. One of the metabolites produced
was extracted, isolated using HPLC and identified by NMR, MS and
crystallography as the known octaketide product prechrysophanol by Dr.
John Bauer. The isolation of prechrysophanol provides another hint to the
biosynthetic origin of erdacin suggesting that the erdacin minimal PKS may
produce a nascent octaketide backbone.
Three of the remaining compounds observed in R2YE cultures had odd
masses ([M +H]+ m/z 228, 254, and 268) suggesting they contained a
nitrogen and were distinct from erdacin and its predicted biosynthetic
intermediates. Two of these metabolites were extracted and fractionated by
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silica flash chromatography with a CHCl3/MeOH step gradient. The fraction
containing both of these compounds was further partitioned by reverse phase
HPLC. HRMS data was collected on these two metabolites named utahmycin
A (observed m/z 254.0829 [M + H]+ (calcd for C15H12NO3, 254.0817)) and
utahmycin B (obsered m/z 228.0672 [M + H]+ (calcd for C13H10NO3,
228.0661)). The structure of utahmycin B was resolved by Dr. John Bauer
using MS,
13CNMR,

1HNMR

and HMBC NMR data. Missing publication quality

COSY, HMBC, HMQC and other empirical data of utahmycin B

was collected for this thesis after obtaining more material.
Work toward this thesis resolved the structure of utahmycin A using
1H, 13C,

COSY, HMBC and HMQC NMR spectra (Figure 16). Proton NMR of

utahmycin A revealed two methyl singlets, four aromatic protons and an
alcohol. COSY and 1HNMR showed three of the aromatic protons form a
proton spin system (d-t-d) and the remaining aromatic proton is a singlet.
Carbon NMR and HMQC revealed the two methyl carbons, two carbonyls,
three olefins directly attached to heteroatoms, four olefins attached to a
hydrogen and four additional olefins. The H-5, 6 and 7 proton spin system
could be assembled into an aromatic ring with C-8, 11 and 12 based on
HMBC correlations. The high deshielding of C-8 and HMBC correlations from
the alcohol to C-7, 8 and 12 enabled the alcohol to be positioned on C-8. One
of the two carbonyls (C-10) could be placed adjacent to C-11 based on an
HMBC correlation between H-5 and C-10. C-10 also had an HMBC
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correlation to the singlet H-4. Additional HMBC correlations from H-4 to C-3,
13, 14 and 16 were used to assemble the framework for the second half of
utahmycin A. This was further supported by correlations from the methyl H16 protons to C-3 and C-4. The second methyl group and the final olefin could
both be connected to the structure based on correlations between H-15
protons and C-1 and 13. In this structure both of the methyl groups are
attached to deshielded olefins (C-1 and C-3) that are attached directly to a
heteroatom. With only a nitrogen and carbonyl left to place, the only way to
satisfy the deshielded

13C

chemical shifts is to connect C-1 and C-2 through a

nitrogen. The remaining carbonyl (C-9) could then only be placed one way to
meet the unsaturation requirements of the chemical formula, between C-12
and C-13. The structure of utahmycin A was further confirmed by X-ray
crystallography.

Figure 16: Structural elucidation of Utahmycin A and B.
A) Key 1H-1H and 1H-13C correlations used to elucidate the structures of Utahmycin A (24)
and B (25) are shown. B) The structure of Utahmycin A was confirmed by X-ray
crystallography (grey = carbon, red = oxygen and blue = nitrogen).
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The third nitrogen-containing metabolite, obtained in much lower
titers (< 0.5mg/L), was isolated. HRMS and 1HNMR of this metabolite,
suggested a compound related to the other two utahmycins. The absence of a
hydroxyl signal and the appearance of a deshielded methyl group in 1HNMR
was consistent with HRMS data (HRMS (ESI) m/z 268.0953 [M+H]+, calcd.
for C16H14NO3, 268.0974) and an O-methylation of utahmycin A.
The structure of Utahmycin A is novel and is the first 1,3-dimethyl-2azaanthrqquinone reported from a biological system. While utahmycin B has
been previously synthesized, it has not been observed in a biological system.
2-azaanthraquinones have primarily been isolated from fungi and lichens
and present a wide range of activity from antibacterial to antimalarial
activity (Figure 17b) (Zhang, Watanabe et al. 2006). In fungi 2azaanthraquinones are typically found with structurally related metabolites,
which contain an oxygen in place of the nitrogen of 2-azaanthraquinones
(Medentsev, Akimenko et al. 1988; Parisot, Devys et al. 1990; Kurobane,
Vining et al. 1980; Kurobane, Zaita et al. 1986). No antibiotic activity was
observed when utahmycin A and B (50-100µg/disk) were assayed against a
number of Gram-positive and Gram-negative microbes in a disk diffusion
assay. The isolation of erdacin, utahmycin A, utahmycin B and

8-O-

methylutahmycin A from a single eDNA-derived clone, indicates that eDNAderived type-II PKS gene clusters are a rich source of novel natural products.
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Figure 17: Metabolites of the eDNA-derived V167 clone.
A) Multiple metabolites were isolated from S. albus transformed with the V167 clone. These
included the novel structure erdacin, utahmycin A, utahmycin B, 8-O-methylutahmycin A
and the known polyketide prechrysophanol. B) Known 2-azaanthraquinones.

Biosynthesis of Erdacin
Knockouts and octaketide shunt products
A biosynthetic analysis of the eDNA-derived type-II PKS gene cluster
that encodes for the novel structure and pentacyclic ring arrangement of
erdacin

was

done.

This

biosynthetic

analysis

included

transposon

mutagenesis experiments to generate a number of single gene knockout
erdacin gene clusters. Single gene knockouts of the retrofitted V167 clone
were created by insertion of a chloramphenicol resistance gene using the
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Genome Priming System with GPS -2.1 (NEB, Ipswich, MA). The location of
®

insertion was determined for 150 unique transposon mutants by Sanger
sequencing. Due to the high GC content (>90%) of large regions of the Erd
gene cluster, transposon insertions did not distribute evenly throughout the
eDNA insert and, therefore, no transposon insertions were identified in
several GC rich genes. A large number of unique transposon mutants were
individually mated into S. albus and visually screened for phenotypic
changes. The chemotypes of individual transposon mutants, which either
exhibited a phenotypic change or were found in genes of interest by
sequencing, were analyzed by analytical LC-MS and TLC of culture extracts.
Transposon mutants effecting the expression of erdacin all fell within a
20 kb region of the V167 clone, which was defined as the erdacin gene cluster
(Figure 18b). The 20 kb erdacin gene cluster contains 22 predicted ORFs
including the expected minimal PKS (Erd1, -2, and -3), ketoreductase (Erd5),
cyclase (Erd22) and aromatase (Erd4) of PKS gene clusters. A collection of
post-PKS

enzymes,

regulatory

proteins,

a

transporter,

a

4'-

phosphopantetheinyl transferase and several hypothetical proteins are also
located within the gene cluster. Transposon knockouts of the minimal PKS
(Erd-1, -2, and -3) and a transcriptional activator (Erd-9) abolished clone
specific secondary metabolite production. And clones with insertions in Erd4,
-5, -20 and -22 showed a change in chemotype by visual inspection and LCMS of extracts (Figure 18a)
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Figure 18: V167 transposon mutants.
A) Color changes observed in extracts of S. albus conjugated with mutant erdacin gene
clusters. B) The locations of key transposon insertions in the erdacin gene cluster.

The compounds found in extracts of S. albus transposon mutants
ΔErd4, -5, -20 and -22 were extracted, isolated and identified by MS and
NMR to develop a better understanding of the erdacin gene cluster. Extracts
of ΔErd5 ketoreductase mutant cultures were found to contain the known
octaketide shunt products SEK4b and AUR367. These two compounds are
derived from an alternative first cyclization that occurs when the nascent
polyketide backbone partially falls off the minimal PKS (Fu, Hopwood et al.
1994; Seow, Meurer et al. 1997). This alternative first cyclization indicates a
failure of the minimal PKS to cyclize the nascent polyketide backbone and is
known to occur when the proper minimal PKS-ketoreductase complex does
not form (other Ref on ketoreductase). Two more known octaketide shunt
products, mutactin and dehydromutactin, were isolated from extracts of the
ΔErd4 aromatase mutant. The presence of mutactin and dehydromutactin is
consistent with an octaketide PKS gene cluster with an aromatase knockout
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(Zhang, Adefarati et al. 1990; Fu, Khosla et al. 1994; Staunton and
Weissman 2001; Meisner, Hintersteiner et al. 2007). Furthermore, SEK34
and SEK34b were isolated from crude extracts of the ΔErd22 cyclase mutant.
X-ray crystallography was used to confirm the structure of SEK34b. The
observation of SEK34 and SEK34b is consistent with a cyclase knockout
(McDaniel, Khosla et al. 1994; Staunton and Weissman 2001). The deletion
of Erd20, a predicted FAD-dependant monooxygenase, led to the production
of the known octaketide product prechrysophanol (also identified in R2YE
cultures of wild-type V167) and a number of other compounds with a range of
molecular weights from m/z 240 to 315.
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Figure 19: Biosynthetic scheme of metabolites produced by V167 early post-PKS
gene knockouts.
SEK4b, AUR367, mutactin, dehydromutactin, SEK34 and SEK34b were isolated from
cultures of early erdacin PKS gene knockouts. These metabolites isolated from cultures of
ΔErd4, ΔErd5 or ΔErd22 mutants are known octaketide metabolites, indicating erdacin is
derived from a 16-carbon backbone.
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Figure 20: Biosynthetic scheme for the production of erdacin.
Evidence indicates that erdacin may be derived from the dimerization of two 13-carbon
subunits, but the erdacin minimal PKS appears to produce an octaketide. A biosynthetic
scheme for the production of these two 13-carbon monomers from an octaketide is shown.
Utahmycin A, utahmycin B and prechrysophanol, isolated from wild type V167 cultures, are
derived from intermediates in the proposed biosynthesis of erdacin.
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Knockouts of early PKS genes lead to the production of known
octaketide shunt products, suggesting that the minimal PKS of erdacin
produces an octaketide backbone. However, the isolation of juglomycin F from
wild type cultures hints that erdacin is derived from the heterodimerization
of two distinct 13-carbon subunits (Figure 15). A biosynthetic scheme is
proposed where two 13-carbon subunits of erdacin are derived from the
excision of three carbons from octaketide precursors produced by the minimal
PKS (Figure 19 and 20). While the isolation of juglomycin F from wild type
cultures supports the existence of one 13-carbon intermediate, the second 13carbon subunit was not identified. The two most likely possibilities of the
origin of the second 13-carbon subunit share a common first cyclization with
the juglomycin F monomer and are then derived from a rearrangement or an
alternate second cyclization (Figure 20). This biosynthetic scheme is further
supported by the isolation of prechrysophanol (27), utahmycin A (24) and
utahmycin B (25), which are derived from various biosynthetic intermediates
of erdacin production. Prechrysophanol, observed in wild type and ΔErd20
mutant cultures, is a known decarboxylated octaketide and its biosynthesis is
understood. Utahmycin A and B both appear to be derived from the
incorporation of nitrogen into erdacin biosynthetic intermediates (Figure 20).
Further evidence that the erdacin minimal PKS produces an
octaketide comes from sequencing data that revealed Erd1, -2, and -3 are
most closely related to the minimal PKS genes of the octaketide encoding
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naphthocyclinon, actinorhodin, granaticin and medermycin pathways (Figure
13). Naphthocyclinon (22) and actinorhodin (13) are both octaketide dimers,
which arise from two different dimerization strategies (McDaniel, Khosla et
al. 1994; Ichinose, Bedford et al. 1998; Brucker, McKinney et al. 1999;
Ichinose, Ozawa et al. 20003). Interestingly, erdacin appears to use an
alternative octaketide heterodimerization strategy.
Cyclization Pattern of Erdacin
Knockout

experiments

suggest

that

octaketide

precursors

are

converted into two 13-carbon monomer subunits that heterodimerized to
produce erdacin. One of these 13-carbon monomers is represented by
juglomycin F, isolated from wild type V167 cultures. A number of possibilities
of the origin of the unidentified second 13-carbon subunit exist, including the
two most likely possibilities that share a common first cyclization with the
juglomycin F monomer and are then derived from a rearrangement or an
alternate cyclization. An [1,2-13C]acetate feeding experiment was conducted
to distinguish the numerous folding pattern possibilities that could result in
the second 13-carbon monomer.
Cultures of the V167 clone were feed one part labeled [1,2-13C]acetate
and two parts naturally abundant acetate. The labeled [1,2-13C]acetate units
were incorporated into erdacin by the bacteria during biosynthesis and the
resulting labeled erdacin was isolated. On average, every incorporated
labeled acetate unit was adjacent to two non-labeled acetate units.
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13C-13C

coupling between the two carbons of labeled acetate units in 1- and 2D
13CNMR

of [1,2-13C]acetate-labeled erdacin was then used to determine which

carbons in erdacin were incorporated as intact acetate units. For example, C23 appears as a singlet in

13CNMR

of [1,2-13C]acetate-labeled erdacin,

however, C-23 shows coupling to C-22 and appears as a doublet in 13CNMR of
erdacin that is uniformly labeled with

13C

(Figure 21a). The absence of

coupling between C-23 and C-22 in the acetate labeled erdacin indicates that
C-22 and C-23 arise from different acetate units during biosynthesis.
The experimentally observed folding pattern of erdacin is consistent
with the octaketide (Sʹ′)-folding of the juglomycin F monomer in the proposed
biosynthetic scheme (Figure 20). Specifically, observed coupling between C-20
to C-21, C-18 to C-19, and C-16 to C-17 of erdacin in these labeling
experiments supports the proposed folding pattern of the juglomycin F
monomer of erdacin (Figure 21, 22a). This proposed folding pattern is further
supported by the absence of coupling between C-23 and C-22 in 1D
acetate labeled experiments, which can be observed by
uniformly

13C-labeled

13CNMR

13CNMR

if erdacin is

(Figure 21a). This folding pattern of the juglomycin F

monomer resembles the octaketide Streptomyces (Sʹ′)-folding of chrysophanol
and actinorhodin (Bringmann, Irmer et al. 2009). Utahmycin A and B are
also derived from this octaketide folding pattern. This differs from other
known 2-azaanthraquinones, which are derived from a fungal (F)-folding of a
septaketide (Thomas 2001; Van Wagoner, Mantle et al. 2008). Utahmycin A
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and B are derived from both an alternative folding pattern and a larger
polyketide precursor than previously known fungal 2-azaanthraquinones.
There are a number of possibilities for the biosynthetic origins of the
hypothetical second 13-carbon subunit (Figure 22b). The two most likely
possibilities share a common first cyclization with the juglomycin F monomer
and are then derived from a rearrangement (i) or an alternate cyclization (ii).
If the two 13-carbon monomers share common first and second cyclization
patterns and the second monomer arises from a rearrangement (i), coupling
between C-26 and C-25 is expected, but C-24 would not couple with the
adjacent C-12 in erdacin. However, these couplings expected of this folding
pattern were not observed in 2D INADEQUATE experiments (Figure 21a). In
fact, coupling was observed between C-24 and C-12, but coupling was not
observed for C-26. Furthermore, C-25 and C-13 appear to come from the same
acetate

unit,

as

coupling

was

observed

INADEQUATE data was supported by 1D
coupling of uniformly

13C-labled

between

13CNMR

them.

This

data comparing

2D

13C-13C

and [1,2-13C]acetate-labeled erdacin (Figure

21a). This observed coupling is consistent with the second monomer arising
from a common first cyclization, but an alternative second cyclization to the
juglomycin F monomer (ii). This folding pattern of an alternative second
cyclization (ii) is the most likely biosynthetic possibility supported by the
observed data.
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Figure 21: The cyclization pattern of erdacin and two 13-carbon precursors.
(A) Observed

13C-13C

coupling of [1,2-13C]acetate-labeled erdacin in

13CNMR

and

INADEQUATE NMR spectra. (B) Coupling data suggests the two 13-carbon monomers that
make up erdacin are derived from two different cyclization patterns.
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Figure 22: Biosynthetic possibilities of the labeled acetate feeding experiment.
The expected carbon couplings of several possible folding patterns for the 13-carbon
monomers that makeup erdacin and the experimentally determined folding patterns of the
two monomers. (A) The observed folding pattern of erdacin is consistent with the proposed
octaketide (Sʹ′)-folding of the Juglomycin F monomer similar to chrysophanol and
actinorhodin (Figure 20). (B) Several possibilities for the biosynthetic origins of the second
13-carbon monomer are shown. (i) The second 13-carbon monomer could share a common
first and second cyclization with the juglomycin F monomer and arise from a rearrangement
of one of the carbons. The expected folding pattern of this possibility is not consistent with
the observed folding pattern of the second ring. (ii) The second monomer could be derived
from a common first cyclization, but an alternative second cyclization (Figure 20). The
observed folding pattern is consistent with the expected folding pattern of this possibility and
is the most likely biosynthetic possibility supported by the observed data. (iii) Another
alternative second cyclization is also consistent with the observed data, but can be ruled out
as it is inconsistent with known polyketide biosynthesis. (iv) An alternative first cyclization
that resembles the fungi specific (F)-folding pattern is an unlikely possibility, as the erdacin
gene cluster appears to be derived from Streptomyces. (v) The expected folding pattern of
another alternative first cyclization resulting in (S)-folding similar to chrysophanol is not
consistent with the observed folding pattern of the second ring. (vi) Another possibility could
have the same first (S)-folding cyclization as v, but have an alternative second cyclization
pattern. The expected folding pattern of this possibility is also consistent with the observed
folding pattern, however, this possibility is unlikely as it would require the minimal PKS of
erdacin to catalyze two different first cyclization reactions.
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Another biosynthetic possibility for the origin of the second 13-carbon
monomer of erdacin is a second folding pattern that shares a common first
cyclization with the juglomycin F monomer, but has an alternative second
cyclization (iii). In this biosynthetic possibility, the second 13-carbon
monomer would arise from a rearrangement and loss of three carbons from
the (S`)-folded octaketide 34. Alternatively, the same coupling pattern could
be derived from the loss of three carbons from the (S)-folded octaketide 35. In
either case, the expected coupling of this folding pattern would be consistent
with the observed data (Figure 22b iii), but inconsistent with polyketide
biosynthesis. In fact, this possibility would require the addition of an oxygen
functional group to four different carbon positions and the removal of oxygen
from at least two additional carbons. Possibility iii is consistent with
observed data, but can be ruled out because it is inconsistent with known
polyketide biosynthesis.
Three other possibilities arise from alternative first cyclizations of the
octaketide backbone. An alternative first cyclization that resembles the fungi
specific (F)-folding pattern is inconsistent with observed data and is unlikely
as the erdacin gene cluster appears to be derived from Streptomyces (iv). The
expected folding pattern of an alternative first cyclization leading to (S)folding is inconsistent with the observed folding pattern of the second ring
(v). However, another possibility could share a first (S)-folding cyclization
with possibility v, but have an alternative second cyclization pattern (vi). The
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expected folding pattern of this possibility is also consistent with the
observed folding pattern. However, this possibility is unlikely as it would
require the minimal PKS of erdacin to catalyze two different first cyclization
reactions. Furthermore, a rearrangement would be required, making
possibility vi far more complex than ii.
The possibility most consistent with known biosynthetic precedent that
was supported by 1- and 2D

13CNMR

data from the acetate feeding

experiment, suggests the second 13-carbon monomer shares a first cyclization
with the juglomycin F monomer and then arises from an alternate second
cyclization. Interestingly, the biosynthetic scheme suggested by this data
utilizes an alternate second cyclization, but results in the same three carbons
being excised from the octaketide precursors of both monomers (Figure 21b).
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CHAPTER 4

Discussion
Abundance of type II PKS gene clusters in eDNA from soil
Uncultured bacteria are thought to encode for a plethora of previously
undiscovered small molecules. Libraries of DNA isolated from environmental
samples were used to access the genetic diversity of these uncultured
microbes. Previous studies have indicated that eDNA samples are rich in
Type II PKS genes (Wawrik, Kerkhof et al. 2005; Pang, Tan et al. 2008;
Wawrik, Kutliev et al. 2007). Sequencing of KSβ gene amplicons from the UT
and AB libraries confirmed eDNA libraries are rich in PKS gene clusters. In
fact, 21 unique KSβ genes were amplified from the UT library and another 31
were identified in the AB library. Only two of the genes identified in the AB
and UT libraries showed greater than 80% identity to known KSβ genes. The
remaining pathways all had less than 80% identity to previously sequenced
KSβ genes and likely encode for novel small molecules. However, no new
metabolites have been produced from eDNA-derived type II PKS gene
clusters prior to this work.
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Novel structures from uncultured bacteria
To explore the structural diversity encoded by uncultured bacteria,
cosmids containing type II PKS gene clusters were recovered from an eDNA
library using KSβ genes as a probe. The recovered clones were heterologously
expressed in S. albus and screened for the production of clone specific
metabolites. A number of the clones isolated from the AB and UT libraries
were found to produce clone specific metabolites. One of these clones (V167)
was selected for further characterization, because it produced large
quantities of a stable clone specific metabolite. The molecule the V167 clone
encodes for was structurally elucidated. This metabolite, erdacin, was found
to have not only a novel carbon skeleton, but also a novel pentacyclic ring
arrangement. The structural elucidation of the novel secondary metabolite
erdacin provides tangible evidence that eDNA-derived type II PKS gene
clusters have the potential to encode for metabolites that are structurally
distinct from those identified by culture-dependent studies.
In addition to erdacin, a number of other clone specific novel and
known metabolites were characterized from cultures of S. albus harboring
the V167 clone. These metabolites included utahmycin A, utahmycin B and 8O-methylutahmycin A. The structure of Utahmycin A is novel and utahmycin
B has not been previously observed in a biological system. The utahmycins
appear to arise from the incorporation of nitrogen into erdacin biosynthetic
intermediates. Since there is no predicted amino transferase in the erdacin
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gene cluster, the utahmycins are likely derived from erdacin biosynthetic
intermediates independent of the erdacin gene cluster. Whether the
utahmycins have a biological function in the uncultured microbe from which
the erdacin gene cluster was derived or if they are unintended shunt products
of erdacin biosynthesis is unknown. Regardless, the isolation of additional
distinct novel metabolites from the same eDNA clone encoding the
biosynthesis of erdacin, suggests that eDNA-derived type-II PKS gene
clusters are a rich source of natural products.
Sequencing of KSβ amplicons has found the AB and UT eDNA libraries
are rich in type II PKS gene clusters. The isolation of the novel metabolite
erdacin provides tangible evidence that these eDNA-derived gene clusters may
encode for the biosynthesis of small molecules that are distinct from compounds
isolated by culture-dependant strategies. Isolation of the utahmycins suggests
that heterologous expression of these PKS gene clusters may yield, in some
cases, multiple metabolites from a single clone. There is now precedent that
the recovery and screening of clones, containing eDNA-derived type II PKS
gene clusters, for the ability to confer production of clone-specific metabolites
to Streptomyces will be a rewarding avenue to access the structural diversity
of natural products encoded by uncultured soil bacteria.
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Biosynthesis of erdacin and the utahmycins
The novel structure and pentacyclic ring arrangement of erdacin raised
questions as to its biosynthetic origins. To develop a better understanding of
the origin of erdacin, a biosynthetic analysis of the V167 clone utilizing
transposon mutagenesis and [1,2-13C]acetate feeding experiments was
conducted. The isolation of juglomycin F from wild type V167 cultures,
provided an initial hint to the biosynthetic origin of erdacin. The structure of
juglomycin F maps onto half of the erdacin structure; suggesting it may arise
from the heterodimerization of two 13-carbon subunits. However, transposon
knockouts of early PKS genes lead to the production of known octaketide
shunt products, indicating that the minimal PKS of erdacin produces an
octaketide backbone. A minimal PKS encoding an octaketide is further
supported by the isolation of the octaketide product prechrysophanol from
cultures of mutant and wild type V167. Additionally, the folding pattern
leading to the novel ring system of erdacin was assessed in an [1,213C]acetate

feeding study to learn more about the origins of the two 13-carbon

subunits that make up erdacin.
While the exact structure of late-stage polyketides used in erdacin
biosysnthesis is unknown, a biosynthetic scheme where erdacin is derived
from two 13-carbon subunits was proposed. In this biosynthetic scheme, the
erdacin minimal PKS encodes for an octiketide and the two distinct 13-carbon
monomers are derived from a common octaketide precursor. Two distinct
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second

cyclizations

diverge

the

biosynthesis

of

the

two

13-carbon

intermediates. At some point, both of the 13-carbon intermediates have the
same three carbons excised from their octaketide precursors. These two 13carbon monomers would then heterodimerize to form erdacin.
The utahmycins appear to arise from the incorporation of nitrogen into
erdacin biosynthetic intermediates. There is no predicted amino transferase
in the erdacin gene cluster and the utahmycins are likely derived from
biosynthetic intermediates independently of the erdacin gene cluster. Data
from [1,2-13C]acetate-label erdacin implies the folding pattern of the
utahmycins

resembles

the

octaketide

Streptomyces

(Sʹ′)-folding

of

chrysophanol (Bringmann, Irmer et al. 2009). This differs from other known
2-azaanthraquinones, which are derived from a fungal (F)-folding of a
septaketide (Thomas 2001; Van Wagoner, Mantle et al. 2008). Utahmycins
are derived from both an alternative folding pattern and a larger polyketide
precursor than previously known fungal 2-azaanthraquinones.

Activity of eDNA-derived metabolites
Since the bacteria that eDNA is derived from remain uncultured, it can
be difficult to determine the function of novel eDNA-derived metabolites in
their native organism. No antibacterial activity was detected when erdacin
and the utahmycins were assayed against a number of Gram-positive and
Gram-negative microbes in an antibacterial agar disk diffusion assay. And
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erdacin did not appear to have an effect when cultured with mammalian cell
lines. Erdacin was, however, found to have twice the antioxidant activity as
the known antioxidant ascorbic acid (vitamin C).

Cryptic eDNA-derived clones and future directions
In addition to the V167 clone, a number of other clones containing PKS
genes were recovered from the UT and AB libraries. Screening of the recovered
clones containing minimal PKS genes revealed a number of clones able to confer the
production of clone-specific molecules to cultured Streptomyces albus. However,
some of the clones recovered from the libraries produced a large amount of
unstable clone specific metabolites and others were cryptic clones. The X26
clone is one such cosmid that produced an array of unstable metabolites. Dr.
John Bauer’s sequencing of X26 revealed a minimal PKS and truncated gene
cluster. A cosmid that captured an incomplete PKS gene cluster from eDNA
could explain the array of unstable clone specific metabolites observed in X26
cultures.
The	
  ability	
  to	
  access	
  the	
  metabolites	
  encoded	
  by	
  these	
  truncated	
  and	
  cryptic	
  
pathways	
  would	
  greatly	
  increase	
  the	
  number	
  of	
  novel	
  compounds	
  found	
  from	
  eDNA	
  
libraries.	
  A	
  number	
  of	
  strategies	
  have	
  been	
  utilized	
  in	
  subsequent	
  studies	
  to	
  access	
  
the	
   structural	
   diversity	
   of	
   these	
   PKS	
   gene	
   clusters.	
   In	
   one	
   approach,	
   missing	
   PKS	
  
biosynthetic	
   enzymes	
   not	
   present	
   in	
   the	
   truncated	
   X26	
   clone	
   were	
   found	
   by	
  
recovering	
   a	
   second	
   overlapping	
   eDNA	
   clone	
   representing	
   the	
   same	
   PKS	
   gene	
  
cluster.	
   The	
   reconstruction	
   of	
   these	
   two	
   overlapping	
   clones	
   into	
   a	
   single	
   Bacterial	
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artificial	
   chromosome	
   (BAC)	
   and	
   the	
   subsequent	
   heterologous	
   expression	
   of	
   the	
  
reconstructed	
  PKS	
  pathway	
  resulted	
  in	
  the	
  discovery	
  of	
  a	
  second	
  novel	
  ring	
  system	
  
from	
  eDNA	
  (Kim,	
  Feng	
  et	
  al.	
  2010;	
  Feng	
  ,	
  Kallifidas	
  et	
  al.	
  2011;	
  Kallifidas	
  and	
  Brady	
  
2012).	
  
While S. albus has been utilized with great success in this work and
subsequent studies to heterologously	
   express eDNA-derived PKS gene
clusters, alternative Streptomyces heterologous hosts may more closely
resemble some of the uncultured native organisms that these eDNA gene
clusters are derived from. In fact, it has been reported that eDNA clones will
present distinctive phenotypes in different hosts and that the same
phenotype is rarely conferred to two different hosts (Craig, Chang et al. 2009;
Craig, Chang et al. 2010). Expression of eDNA-derived PKS gene clusters in
alternative Streptomyces heterologous hosts may lead to the production of
metabolites from cryptic clones (Wang, Isaacs et al. 2009; Komatsu,
Uchiyama et al. 2010). Another approach to accessing the metabolites
encoded by cryptic eDNA clones is through the overexpression of
transcription factors from eDNA-derived PKS gene clusters. A recent study
has reported the successful use of a constitutively expressed pathway-specific
Streptomyces antibiotic regulatory protein to promote the production of
tetarimycin A from a previously cryptic eDNA clone (Kallifidas, Kang et al.
2012).
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An alternative strategy to increase the number of natural products
discovered from eDNA libraries is to build a library enriched with PKS gene
clusters. Recently, the complementation of phosphopantetheine transferase
(PPTase) deletion mutants with the PPTase genes found in some eDNA
clones was successfully leveraged as a filter to construct an NRPS/PKS
enriched eDNA library (Charlop-Powers, Banik et al. 2013). These advances
and additional new approaches will continue to enhance our ability to access
the incredible structural diversity of natural products that are encoded by
uncultured bacteria.

Sequencing advances and future directions
As sequencing technology continues to develop in both speed and cost
effectiveness it will have a profound impact on the field of metagenomics
(Chan, Hsu, et al. 2008; Morozova and Marra 2008; Yang, Peng et al. 2010).
In fact, there are already efforts to sequence the first complete soil
metagenome (Vogel, Simonet, et al. 2009). The data presented here and in
other studies indicates that the genetic diversity encoded by uncultured
bacteria is an affluent source of natural products that are distinct from those
identified by traditional culture-dependant studies. Metagenomic methods
will

likely

be

a

rewarding

avenue
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for

future

research

efforts.

APPENDIX
Table 8: Chemical shift table of Erdacin in MeOD with 0.1% TFA.
Proton δ (J Hz)

1

120.6

7.16 (d, 7.1, 1H)

5, 6, 8, 9, 11

131.3

7.28 (t, 7.7, 1H)

6, 7, 10, 11

118.7

6.92 (d, 7.7, 1H)

6, 7, 8, 10, 11, 12

4.29 (s, 1H)

5, 11, 12, 14, 15, 24, 25, 26

119.1

7.40 (m, 1H)

15, 16, 19, 20, 21

138.8

7.40 (m, 1H)

118.4

6.73 (d, 7.7, 1H)

17, 20, 21

30.3
176.6
203.5

2.53 (s, 3H)

4, 22

27.9

1.72 (s, 3H)

13, 25

Atom #
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22

Chemical δ

23
24
25
26

H-13C HMBC

188.4
153.7
127.7
131.2
143.3
133.4

156.7
123.8
75.5
64.6
134.6
130.6
135.6

165.3
114.1
205.5

OH O

O

O

N
HO
O

1

2

N

O
3 4

O
Utahmycin A

22

HO

OH O
HO
O O
Erdacin
25

24

OH
OH

H
N

O
8-O-methylutahmycin A

OH

OH

O
OH

O
Utahmycin B
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Prechrysophanol

Table 9: Genes of the Erdacin pathway and their deduced role.
Gen
e

ORF
4
Erd
1
Erd
2
Erd
3
Erd
4
Erd
5
Erd
6
Erd
7
Erd
8
Erd
9
Erd
10
Erd
11
Erd
12
Erd
13
Erd
14
Erd
15
Erd
16
Erd
17
Erd
18
Erd
19
Erd
20
Erd
21
Erd
22
ORF
27
ORF
28

Size

Deduced Role

Homologues

(aa)

Gene

Deduced role

%
SM/I
D

Origin

accession #

251

SSAG_02590

Acetyltransferase

77/72

Streptomyces sp.

EDX22799

430

Keto-acyl synthase α (KSα)

ORF1

Keto-acyl synthase α (KSα)

94/90

S. antibioticus

CAC05671

407

Keto-acyl synthase β (KSβ)

ORF2

Keto-acyl synthase β (KSβ)

83/72

S. antibioticus

CAC05672

89

Acyl carrier protein (ACP)

ORF3

Acyl carrier protein (ACP)

87/77

S. antibioticus

CAC05673

316

Aromatase

ORF4

putative aromatase

82/71

S. antibioticus

CAC05674

261

Keto reductase

ORF5

putative keto reductase

92/86

S. antibioticus

CAC05675

153

ActVI-A like

gra-orf31

unknown/aromatase

78/66

S. violaceoruber

CAA09658

317

Acyl-CoA dehydrogenase
4'-phosphopantetheinyl
transferase
Pathway-specific
transcriptional activator

YP_002192995

acyl-CoA dehydrogenase

39/28

S. clavuligerus

YP_002192995

pSLA2-L_p056

4'-phosphopantetheinyl transferase

59/50

S. rochei

NP_851478

gra-orf9

AlnR3 SARP family regulator

71/59

S. violaceoruber

CAA09630

266
272
192

ABB04148

phenylalanine ammonia lyase

39/31

Rhodotorula glutinis

ABB04148

gra-orf11

two-component sensory kinase

54/40

S. violaceoruber

CAA09632

191

HP
Two component sensory
kinase
Two-component response
regulator

gra-orf10

two-component response regulator

81/65

S. violaceoruber

CAA09631

413

Major facilitator transporter

RHA1_ro10147

major facilitator transporter

64/50

YP_708498

344

Putative aldo/keto reductase

AZC_4378

Putative aldo/keto reductase

66/52

YP_001527294

226

Membrane protein

RPC_3500

HP

69/56

Rhodococcus sp.
Azorhizobium
caulinodans
Rhodopseudomonas
palustris

110

HP

ZP_01548508

putative glyoxalase family protein

44/28

Labrenzia aggregata

ZP_01548508

157

HP

RTM1035_00205

Transcriptional regulator

RSal33209_1249

HP
MarR family transcriptional
regulator

55/42

104

Roseovarius sp.
Renibacterium
salmoninarum

YP_001624400

206

SGR_4078

putative flavodoxin

79/66

S. griseus

YP_001825590

remO

FAD-dependent monooxygenase

74/62

Aln5

HP/keto reductase Assesory protein

64/48

S. resistomycificus
Streptomyces sp.
CM020

CAE51184

125

Flavodoxin
FAD-dependent
monooxygenase
HP/keto reductase Assesory
protein

302

Cyclase

gra-orf33

cyclase

74/62

S. violaceoruber

CAA09660

SCO0222

acetyltransferase
N5,N10-methylenetetrahydromethanopterin reductase

88/80

S. coelicolor

NP_624554

87/79

S. tsusimaensis

ABA59536

395

406

177
287

75

75/58

YP_533359

ZP_01881455

ACI88872

Table 10: NMR Specroscopic Data (CD2Cl2) for Utahmycin A
position
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
OH

δC, mult.

δH (J in Hz)

HMBC

7.85, s
7.77, dd (7.5, 1.1)
7.69, t ( 7.9)
7.35, dd ( 8.4, 1.1)

3, 10, 13, 16
7, 10, 12
7, 8, 11
5, 8, 12

3.05, s
2.70, s
12.78, s

1, 13
3, 4
7, 8, 12

162.1, qC
165.2, qC
117.8, CH
119.5, CH
136.9, CH
125.8, CH
163.1, qC
190.3, qC
183.1, qC
133.1, qC
117.2, qC
122.8, qC
117.9, qC
26.8, CH3
25.2, CH3
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Table 11: NMR Specroscopic Data (acetone-d6) for Utahmycin B
position
NH (1)
2
3
4
5
6
7
8
9
10
11
12
13
14
OH

δC, mult.

δH (J in Hz)

HMBC

11.77, br, s
140.9, qC
108.2, CH
119.7, CH
136.5, CH
124.5, CH
163.0, qC
180.8, qC
180.5, qC
135.5, qC
116.5, qC
131.9, qC
130.0, qC
13.1, CH3

6.49, s
7.62, m
7.62, m
7.18, dd ( 6.6, 2.8)

2, 9, 12, 13
6, 7, 9, 10, 11
6, 7, 9, 10, 11
4, 5, 7, 11

2.44, s
12.45, s

2, 3
6, 7, 11
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Figure 23: 1HNMR of erdacin in MeOD-d4 with 0.1% TFA
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Figure 24: 13CNMR of 13C uniformly labeled erdacin in MeOD-d4 with 0.1% TFA
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Figure 25: 1HNMR of SEK34b in DMSO-d6
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Figure 26: 1HNMR of Juglomycin F in MeOD-d4
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Figure 27: 1HNMR of prechrysophanol in Acetone-d6
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Figure 28: 1HNMR of SEK4b in DMSO-d6
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Figure 29: 1HNMR of AUR367 in DMSO-d6
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Figure 30: 1HNMR of Mutactin in Acetone-d6
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Figure 31: 1HNMR of Dehydromutactin in DMSO-d6
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Figure 32: 1HNMR of SEK34 in DMSO-d6
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Figure 33: 1HNMR of utahmycin A in CD2Cl2
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Figure 34: 13CNMR of utahmycin A in CD2Cl2
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Figure 35: 1H-13C HMBC of utahmycin A in CD2Cl2
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Figure 36: 1H-13C HMQC of utahmycin A in CD2Cl2
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Figure 37: 1HNMR of utahmycin B in acetone-d6
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Figure 38: 13CNMR of Utahmycin B in acetone-d6
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Figure 39: 1H-13C HMBC of utahmycin B in acetone-d6

94

Figure 40: 1H-13C HMQC of utahmycin B in acetone-d6
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